Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities (vol 140, pg 35, 1999)

被引:0
|
作者
Matsuoka, H
Fors, H
Bosaeus, I
Rosberg, S
Albertsson-Wikland, K
Bjarnason, R
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:268 / 268
页数:1
相关论文
共 47 条
  • [31] Changes in serum leptin levels during r-hGH treatment in growth hormone-deficient children
    Wei, Hong
    Fang, Junming
    Wang, Mudi
    Journal of Huazhong University of Science and Technology - Medical Science, 2001, 21 (04): : 332 - 333
  • [32] Changes in serum leptin levels during r-hGH treatment in growth hormone-deficient children
    Wei Hong
    Fang Junming
    Wang Mudi
    Current Medical Science, 2001, 21 (4) : 332 - 333
  • [33] Improvement in insulin sensitivity without concomitant changes in body composition and cardiovascular risk markers following fixed administration of a very low growth hormone (GH) dose in adults with severe GH deficiency (vol 63, pg 428, 2005)
    Yuen, KCJ
    Frystyk, J
    White, DK
    Twickler, TB
    Koppeschaar, HPF
    Harris, PE
    Fryklund, L
    Murgatroyd, PR
    Dunger, DB
    CLINICAL ENDOCRINOLOGY, 2005, 63 (05) : 599 - 599
  • [34] Changes in insulin sensitivity induced by short-term growth hormone (GH) and insulin-like growth factor I (IGF-I) treatment in GH-deficient adults are not associated with changes in adiponectin levels
    Schmid, C
    Bianda, T
    Zwimpfer, C
    Zapf, E
    Wiesli, P
    GROWTH HORMONE & IGF RESEARCH, 2005, 15 (04) : 300 - 303
  • [35] Growth response to growth hormone (GH) treatment in children with GH deficiency (GHD) and those with idiopathic short stature (ISS) based on their pretreatment insulin-like growth factor 1 (IGFI) levels and at diagnosis and IGFI increment on treatment
    Soliman, Ashraf
    Rogol, Alan D.
    Elsiddig, Sohair
    Khalil, Ahmed
    Alaaraj, Nada
    Alyafie, Fawzia
    Ahmed, Hannah
    Elawwa, Ahmed
    JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM, 2021, 34 (10): : 1263 - 1271
  • [36] Short-term changes in serum leptin levels provide a strong metabolic marker for the growth response to growth hormone treatment in children
    Kriström, B
    Carlsson, B
    Rosberg, S
    Carlsson, LMS
    Albertsson-Wikland, K
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (08): : 2735 - 2741
  • [37] Serum dehydroepiandrosterone sulfate (DHEAS) levels and pubarche in children with Prader-Willi syndrome before and during growth hormone (GH) treatment
    Siemensma, Elbrich P. C.
    de Jong, Frank H.
    Hokken-Koelega, Anita C. S.
    HORMONE RESEARCH, 2009, 72 : 347 - 348
  • [38] Height velocity in short children during second and third years of growth hormone (GH) treatment: Data from the national cooperative growth study (NCGS)
    Bakker, Bert
    Frane, Jim
    Anhalt, Henry
    Lippe, Barbara
    Rosenfeld, Ron
    HORMONE RESEARCH, 2008, 70 : 97 - 97
  • [39] THE GROWTH PARAMETERS OF CHILDREN WITH IDIOPATHIC SHORT STATURE WERE COMPARABLE TO THOSE WITH GROWTH HORMONE DEFICIENCY DURING 3 YEARS' TREATMENT OF DIFFERENT GH DOSE
    Han, Heon-Seok
    Seo, Ah Young
    Kong, Jinkyung
    HORMONE RESEARCH IN PAEDIATRICS, 2017, 88 : 293 - 293
  • [40] Interleukin 1 receptor antagonist is associated with changes in body composition during physiological GH substitution in patients with adult-onset growth hormone deficiency
    Ueland, Thor
    Jorgensen, Anders P.
    Godang, Kristin
    Fougner, Kristian J.
    Aukrust, Pal
    Burman, Pia
    Bollerslev, Jens
    CLINICAL ENDOCRINOLOGY, 2011, 74 (01) : 60 - 66